Combination immune therapy shows promise against Hodgkin lymphoma

(NYU Langone Medical Center / New York University School of Medicine) The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news